Literature DB >> 11557741

Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice.

R H Karas1, H Schulten, G Pare, M J Aronovitz, C Ohlsson, J A Gustafsson, M E Mendelsohn.   

Abstract

The two known estrogen receptors, ERalpha and ERbeta, mediate the effects of estrogen in all target tissues, including blood vessels. We have shown previously that estrogen inhibits vascular injury response to the same extent in female wild-type (WT), ERalpha knockout (ERalphaKO(CH)), and ERbeta knockout (ERbetaKO(CH)) mice. We generated mice harboring disruptions of both ERalpha and ERbeta genes (ERalpha,betaKO(CH)) by breeding and studied the effect of 17beta-estradiol (E2) on vascular injury responses in ovariectomized female ERalpha,betaKO(CH) mice and WT littermates. E2 inhibited increases in vascular medial area following injury in the WT mice but not in the ERalpha,betaKO(CH) mice, demonstrating for the first time that the two known estrogen receptors are necessary and sufficient to mediate estrogen inhibition of a component of the vascular injury response. Surprisingly, as in WT littermates, E2 still significantly increased uterine weight and inhibited vascular smooth muscle cell (VSMC) proliferation following injury in the ERalpha,betaKO(CH) mice. These data support that the role of estrogen receptors differs for specific components of the vascular injury response in the ERalpha,betaKO(CH) mice. The results leave unresolved whether E2 inhibition of VSMC proliferation in ERalpha,betaKO(CH) mice is caused by a receptor-independent mechanism, an unidentified receptor responsive to estrogen, or residual activity of the ERalpha splice variant reported previously in the parental ERalphaKO(CH) mice. These possibilities may be resolved by studies of mice in which ERalpha has been fully disrupted (ERalphaKO(St)), which are in progress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557741     DOI: 10.1161/hh1801.097239

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  39 in total

1.  Placental growth factor mediates aldosterone-dependent vascular injury in mice.

Authors:  Iris Z Jaffe; Brenna G Newfell; Mark Aronovitz; Najwa N Mohammad; Adam P McGraw; Roger E Perreault; Peter Carmeliet; Afshin Ehsan; Michael E Mendelsohn
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  DT56a stimulates creatine kinase specific activity in vascular tissues of rats.

Authors:  D Somjen; I Yoles
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

3.  Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance.

Authors:  R E Stubbins; K Najjar; V B Holcomb; J Hong; N P Núñez
Journal:  Diabetes Obes Metab       Date:  2011-11-22       Impact factor: 6.577

4.  Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males.

Authors:  Adriana Laser; Abhijit Ghosh; Karen Roelofs; Omar Sadiq; Brendan McEvoy; Paul DiMusto; Jon Eliason; Gilbert R Upchurch
Journal:  J Surg Res       Date:  2013-08-18       Impact factor: 2.192

Review 5.  From in vivo gene targeting of oestrogen receptors to optimization of their modulation in menopause.

Authors:  Jean-François Arnal; Françoise Lenfant; Gilles Flouriot; Florence Tremollières; Henrik Laurell; Coralie Fontaine; Andrée Krust; Pierre Chambon; Pierre Gourdy
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

6.  Increased sleep time and reduced energy expenditure contribute to obesity after ovariectomy and a high fat diet.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Sydney P Moak; Jackson R Browning; Xuemei Dai; John E Hall
Journal:  Life Sci       Date:  2018-09-28       Impact factor: 5.037

7.  The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis.

Authors:  Kathryn E Davis; Michael D Neinast; Kai Sun; William M Skiles; Jessica D Bills; Jordan A Zehr; Daniel Zeve; Lisa D Hahner; Derek W Cox; Lana M Gent; Yong Xu; Zhao V Wang; Sohaib A Khan; Deborah J Clegg
Journal:  Mol Metab       Date:  2013-06-04       Impact factor: 7.422

8.  The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol.

Authors:  Audrey Billon-Galés; Coralie Fontaine; Cédric Filipe; Victorine Douin-Echinard; Marie-José Fouque; Gilles Flouriot; Pierre Gourdy; Françoise Lenfant; Henrik Laurell; Andrée Krust; Pierre Chambon; Jean-François Arnal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

9.  Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).

Authors:  V M Miller; D M Black; E A Brinton; M J Budoff; M I Cedars; H N Hodis; R A Lobo; J E Manson; G R Merriam; F Naftolin; N Santoro; H S Taylor; S M Harman
Journal:  J Cardiovasc Transl Res       Date:  2009-05-22       Impact factor: 4.132

10.  Suppressive effects of 17beta-estradiol on hepatic fibrosis in CCl4-induced rat model.

Authors:  Qing-Hua Liu; Ding-Guo Li; Xin Huang; Chun-Hua Zong; Qin-Fang Xu; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.